| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $93.9M | — | -7.5% |
| Cost of Revenue | $67.4M | — | +0.5% |
| Gross Profit | $26.5M | — | -23.0% |
| R&D Expense | $11.4M | — | -6.2% |
| SG&A Expense | $14.5M | — | +13.3% |
| Operating Income | -$11.3M | — | -426.4% |
| Interest Expense | $7.8M | — | +162.9% |
| Pre-tax Income | -$21.2M | — | -537.0% |
| Income Tax | $471K | — | -24.6% |
| Net Income | -$21.7M | — | -448.3% |
| EPS (Basic) | -$0.18 | — | -350.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $63.3M | +10.3% | +7.0% |
| Accounts Receivable | $54.4M | -34.6% | -40.8% |
| Inventory | $155.5M | +10.3% | +0.4% |
| Current Assets | $303.6M | -4.4% | -7.9% |
| Total Assets | $456.8M | -2.9% | -3.4% |
| Current Liabilities | $194.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $12.2M | — | +267.0% |
| Capital Expenditures | $1.9M | — | +70.0% |
| Investing Cash Flow | -$3.8M | — | -241.4% |
| Financing Cash Flow | -$475K | — | +78.1% |
| Free Cash Flow | $10.3M | — | +222.1% |
| -3.6% |
| Long-term Debt | $140.2M | +2.7% | -17.7% |
| Total Liabilities | $394.9M | +1.5% | -7.7% |
| Stockholders' Equity | $61.9M | -23.8% | +36.8% |